Streetbeat News

Products Services

PBM

Psyence Biomedical Ltd (NASDAQ:PBM) has received approval from the Australian Health Research Ethics Committee to begin a Phase IIb study in Melbourne, Australia, focusing on the use of psilocybin for palliative care patients with Adjustment Disorder following a cancer diagnosis. The study, in partnership with iNGENū Pty Ltd, will test different doses of psilocybin combined with psychotherapy. Additionally, Psyence Group has undergone a business restructuring, including a spinout deal resulting in a 37% interest in PBM and the transfer of non-clinical business assets to reduce overhead.

Portfolio Pulse from Lara Goldstein

March 11, 2024 | 11:02 pm

ADBE

KSS

ONON

WallStreetBets users are discussing the upcoming earnings reports for Adobe, On Holdings, and Kohl's. Opinions on Adobe are mixed, with some expecting a decline due to AI competition, while others see Adobe's AI integration as a strength. On Holdings is expected to perform well in its earnings report, with its popularity surging. Kohl's is facing skepticism, with many users planning to buy puts ahead of its earnings report, expecting poor performance.

Portfolio Pulse from Erica Kollmann

March 11, 2024 | 10:01 pm

KLIC

Kulicke and Soffa Industries (KLIC) announced the cancellation of Project W, expecting a reduction in FY24 revenue by approximately $15M. The company plans to redirect its development resources to focus on growth opportunities in Thermo-compression, Vertical Fan-Out, Automotive, and Dispense markets.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:57 pm

STLA

FIAT has announced the next release of its all-electric 500e model, with two versions: Inspired By Music and Inspired By Beauty, each priced at $36,000 including destination fees. This move is part of FIAT's ongoing efforts to expand its electric vehicle lineup.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:49 pm

CRWD

PANW

CrowdStrike Holdings Inc (CRWD) and Palo Alto Networks Inc (PANW) are compared in a cybersecurity stock face-off. CrowdStrike's cloud-native AI platform and rapid market expansion are highlighted, while Palo Alto's diverse product portfolio and acquisition strategy are noted. Despite both stocks trading at high multiples, CrowdStrike's PEG ratio and analyst upside potential suggest it may be the better buy.

Portfolio Pulse from Surbhi Jain

March 11, 2024 | 9:20 pm

AMST

Amesite Inc. has entered into a five-year partnership with Joliet Junior College to provide an advanced learning platform. This collaboration aims to enhance educational experiences through Amesite's innovative technology solutions.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:14 pm

AMD

AMD CEO Lisa Su highlighted AI as the 'most important' technology of the last 50 years, emphasizing its potential for growth and AMD's efforts to capture market share through cloud and edge computing partnerships and AI-powered PCs. Su anticipates 'tremendous growth' in AI over the next three to five years, aiming to make AI accessible to everyone through a range of products.

Portfolio Pulse from Adam Eckert

March 11, 2024 | 9:13 pm

GSM

Ferroglobe and Coreshell have signed a Memorandum of Understanding (MoU) to produce the first battery-grade metallurgical silicon for electric vehicles (EVs), aiming for low-cost, high-range EV batteries in line with the U.S. Inflation Reduction Act.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:12 pm

MRAM

Everspin Technologies has applied for the CHIPS Incentives Program to expand its 200mm MRAM capacity and enhance long-term R&D IP capability.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:08 pm

RUM

Rumble has publicly launched Rumble Cloud, aiming to offer businesses an alternative to incumbent hyperscalers by providing fair pricing, avoiding vendor lock-in, and ensuring freedom from censorship.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 9:07 pm